PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results

Autor: Perry, J., Rogers, L., Laperriere, N., Julian, J., Geerts, W., Agnelli, G., Malkin, M., Sawaya, R., Baker, R., Finch, T., Levine, M.
Zdroj: Thrombosis Research. Jul2007 Supplement 2, Vol. 120, pS157-S157. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: